ArticleOncology nursing forum2025
Advancing Global Cancer Symptom Science: Insights and Strategies From the Inaugural Cancer Symptom Science Expert Meeting.
Article in Oncology nursing forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundThe inaugural "Cancer Symptom Science Expert Meeting," held in Lausanne, Switzerland, on October 11-12, 2023, brought together 40 nurse scientists from seven countries. The event aimed to enhance collaboration across the global symptom science community; identify common research interests, gaps in knowledge, and opportunities for research; and develop strategies to address challenges and accelerate symptom science research internationally.
objectiveThe aim of this white paper is to summarize the discussions and recommendations deliberated during the meeting and introduce the Global Research Alliance in Symptom Science (GRASS).
methodsThis two-day meeting featured presentations that highlighted critical issues and unanswered questions in cancer symptom science and other chronic conditions. Attendees identified four core topic areas based on the knowledge gaps reflected throughout the presentations. Of note, the co-occurrence of cancer with other chronic conditions (e.g., cardiovascular disease, diabetes) that may share similar contributors and underlying mechanisms were included in broader context. Four working groups (WGs) were formed to identify gaps and opportunities associated with each topic and to outline strategic directions and essential actions to advance symptom science.
resultsThe WGs developed recommendations on four core topic areas. WG1 explored optimal approaches to collect, analyze, and use symptom data for research and clinical purposes. WG2 addressed the development of a minimum dataset or common data model for symptom science research. WG3 focused on enhancement of best practices in implementation science strategies to improve uptake of evidence-based symptom management strategies in routine clinical care. WG4 addressed the questions of capacity building and infrastructure for the creation of a global alliance in symptom science (GRASS). DISCUSSION: WGs' recommendations underscore the commitment of an international coalition of scientists to advance symptom science. The symposium established the groundwork for the group to constitute GRASS, a global research alliance dedicated to symptom science in cancer and other chronic conditions. Future directions include establishing regular scientific meetings, fostering interprofessional collaboration, and engaging with symptom scientists.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.